Related Articles
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line
PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency
Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma